Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 3/2007

01-03-2007 | Article

Expression of the gene encoding the high-K m glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy

Authors: R. Li, B. Thorens, M. R. Loeken

Published in: Diabetologia | Issue 3/2007

Login to get access

Abstract

Aims/hypothesis

Excess glucose transport to embryos during diabetic pregnancy causes congenital malformations. The early postimplantation embryo expresses the gene encoding the high-K m GLUT2 (also known as SLC2A2) glucose transporter. The hypothesis tested here is that high-K m glucose transport by GLUT2 causes malformations resulting from maternal hyperglycaemia during diabetic pregnancy.

Materials and methods

Glut2 mRNA was assayed by RT-PCR. The K m of embryo glucose transport was determined by measuring 0.5–20 mmol/l 2-deoxy[3H]glucose transport. To test whether the GLUT2 transporter is required for neural tube defects resulting from maternal hyperglycaemia, Glut2 +/− mice were crossed and transient hyperglycaemia was induced by glucose injection on day 7.5 of pregnancy. Embryos were recovered on day 10.5, and the incidence of neural tube defects in wild-type, Glut2 +/− and Glut2 −/− embryos was scored.

Results

Early postimplantation embryos expressed Glut2, and expression was unaffected by maternal diabetes. Moreover, glucose transport by these embryos showed Michaelis–Menten kinetics of 16.19 mmol/l, consistent with transport mediated by GLUT2. In pregnancies made hyperglycaemic on day 7.5, neural tube defects were significantly increased in wild-type embryos, but Glut2 +/− embryos were partially protected from neural tube defects, and Glut2 −/− embryos were completely protected from these defects. The frequency of occurrence of wild-type, Glut2 +/− and Glut2 −/− embryos suggests that the presence of Glut2 alleles confers a survival advantage in embryos before day 10.5.

Conclusions/interpretations

High-K m glucose transport by the GLUT2 glucose transporter during organogenesis is responsible for the embryopathic effects of maternal diabetes.
Literature
1.
Suhonen L, Hiilesmaa V, Teramo K (2000) Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 43:79–82PubMedCrossRef
2.
Schaefer-Graf UM, Buchanan TA, Xiang A, Songster G, Montoro M, Kjos SL (2000) Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 182:313–320PubMedCrossRef
3.
Loffredo CA, Wilson PD, Ferencz C (2001) Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64:98–106PubMedCrossRef
4.
Wren C, Birrell G, Hawthorne G (2003) Cardiovascular malformations in infants of diabetic mothers. Heart 89:1217–1220PubMedCrossRef
5.
Evers IM, de Valk HW, Visser GH (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in The Netherlands. BMJ 328:915–919PubMedCrossRef
6.
Mills JL, Baker L, Goldman AS (1979) Malformations in infants of diabetic mothers occur before the seventh gestational week: implications for treatment. Diabetes 28:292–293PubMed
7.
Farrell T, Neale L, Cundy T (2002) Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med 19:322–326PubMedCrossRef
8.
Greene MF, Jare JW, Cloherty JP, Cenacerraf BR, Soeldner JS (1989) First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 39:225–231PubMedCrossRef
9.
Miller E, Hare JW, Cloherty JP et al (1981) Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304:1331–1334PubMedCrossRef
10.
The DCCT Research Group (1996) Pregnancy outcomes in the diabetes control and complications trial. Am J Obstet Gynecol 174:1343–1353CrossRef
11.
Uldry M, Thorens B (2004) The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch 447:480–489PubMedCrossRef
12.
Wu X, Freeze HH (2002) GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. Genomics 80:553–557PubMedCrossRef
13.
Hogan A, Heyner S, Charon MJ et al (1991) Glucose transporter gene expression in early mouse embryos. Development 113:363–372PubMed
14.
Aghayan M, Rao LV, Smith RM et al (1992) Developmental expression and cellular localization of glucose transporter molecules during mouse preimplantation development. Development 115:305–312PubMed
15.
Dan-Goor M, Sasson S, Davarashvili A, Almagor M (1997) Expression of glucose transporter and glucose uptake in human oocytes and preimplantation embryos. Hum Reprod 12:2508–2510PubMedCrossRef
16.
Carayannopoulos MO, Chi MM, Cui Y et al (2000) GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst. Proc Natl Acad Sci USA 97:313–318CrossRef
17.
Zhou Y, Kaye PL, Pantaleon M (2004) Identification of the facilitative glucose transporter 12 gene Glut12 in mouse preimplantation embryos. Gene Expr Patterns 4:621–631PubMedCrossRef
18.
Pantaleon M, Harvey MB, Pascoe WS, James DE, Kaye PL (1997) Glucose transporter GLUT3: ontogeny, targeting, and role in the mouse blastocyst. Proc Natl Acad Sci USA 94:3795–3800PubMedCrossRef
19.
Macheda ML, Kelly DJ, Best JD, Rogers S (2002) Expression during rat fetal development of GLUT12—a member of the class III hexose transporter family. Anat Embryol (Berl) 205:441–452CrossRef
20.
Smith DE, Gridley T (1992) Differential screening of a PCR-generated mouse embryo cDNA library: glucose transporters are differentially expressed in early postimplantation mouse embryos. Development 116:555–561PubMed
21.
Trocino RA, Akazawa S, Takino H et al (1994) Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period. Endocrinology 134:869–878PubMedCrossRef
22.
Takao Y, Akazawa S, Matsumoto K et al (1993) Glucose transporter gene expression in rat conceptus during high glucose culture. Diabetologia 36:696–706PubMedCrossRef
23.
Matsumoto K, Akazawa S, Ishibashi M et al (1995) Abundant expression of GLUT1 and GLUT3 in rat embryo during the early organogenesis period. Biochem Biophys Res Commun 209:95–102PubMedCrossRef
24.
Thorens B (1996) Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol 270:G541–G553PubMed
25.
Pessin JE, Bell GI (1992) Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol 54:911–930PubMedCrossRef
26.
Guillam M-T, Hummler E, Schaerer E et al (1997) Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet 17:327–330PubMedCrossRef
27.
Thorens B (2001) GLUT2 in pancreatic and extra-pancreatic gluco-detection. Mol Membr Biol (Review) 18:265–273CrossRef
28.
Sussman I, Matschinsky FM (1988) Diabetes affects sorbitol and myo-inositol levels of neuroectodermal tissue during embryogenesis in rat. Diabetes 37:974–981PubMed
29.
Becerra JE, Khoury MJ, Corder JF, Erickson JD (1990) Diabetes mellitus during pregnancy and the risks for the specific birth defects: a population-based case-control study. Pediatrics 85:1–9PubMed
30.
Martinez-Frias ML (1994) Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 51:108–113PubMedCrossRef
31.
Phelan S, Loeken M (1998) Identification of a new binding motif for the paired domain of Pax-3 and unusual characteristics of spacing and of bipartite recognition elements on binding and transcription activation. J Biol Chem 273:19153–19159PubMedCrossRef
32.
Viana M, Herrera E, Bonet B (1996) Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. Diabetologia 39:1041–1046PubMed
33.
Eriksson UJ (1991) Diabetes in pregnancy: effects on post-implantation embryos. Isr J Med Sci 27:478–486PubMed
34.
Fine E, Horal M, Chang TI, Fortin G, Loeken MR (1999) Hyperglycemia is responsible for altered gene expression, apoptosis, and neural tube defects associated with diabetic pregnancy. Diabetes 48:2454–2462PubMed
35.
Phelan SA, Ito M, Loeken MR (1997) Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46:1189–1197PubMed
36.
Pani L, Horal M, Loeken MR (2002) Polymorphic susceptibility to the molecular causes of neural tube defects during diabetic embryopathy. Diabetes 51:2871–2874PubMed
37.
Silver LM (1995) Mouse genetics: concepts and applications. Oxford University Press, New York
38.
Markel P, Shu P, Ebeling C et al (1997) Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat Genet 17:280–284PubMedCrossRef
39.
Chang TI, Horal M, Jain S, Wang F, Patel R, Loeken MR (2003) Oxidant regulation of gene expression and neural tube development: insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 46:538–545PubMedCrossRef
40.
Boveris A (1977) Mitochondrial production of superoxide radical and hydrogen peroxide. Adv Exp Med Biol 78:67–82PubMed
41.
Turrens JF, Alexandre A, Lehninger AL (1985) Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 237:408–414PubMedCrossRef
42.
Hogan B, Costantini F, Lacy E (eds) (1986) Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor, Cold Spring Harbor, NY
43.
Thorens B, Guillam MT, Beermann F, Burcelin R, Jaquet M (2000) Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. J Biol Chem 275:23751–23758PubMedCrossRef
44.
Cai J, Phelan SA, Hill AL, Loeken MR (1998) Identification of Dep-1, a new gene that is regulated by the transcription factor, Pax-3, as a marker for altered embryonic gene expression during diabetic pregnancy. Diabetes 47:1803–1805PubMed
45.
Cheatham B, Wang L, Blenis J, Kahn, CR (1994) Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14:4902–4911PubMed
46.
Moley KH, Chi MMY, Mueckler MM (1998) Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos. Am J Physiol Endocrinol Metab 38:E38–E47
47.
Li R, Chse M, Jung SK, Smith PJS, Loeken MR (2005) Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 289:E591–E599PubMedCrossRef
48.
Uldry M, Ibberson M, Hosokawa M, Thorens B (2002) GLUT2 is a high affinity glucosamine transporter. FEBS Lett 524:199–203PubMedCrossRef
49.
Spiro RG (1959) Studies on the biosynthesis of glucosamine in the intact rat. J Biol Chem 234:742–748PubMed
50.
Akazawa S, Unterman T, Metzger BE (1994) Glucose metabolism in separated embryos and investing membranes during organogenesis in the rat. Metabolism 43:830–835PubMedCrossRef
Metadata
Title
Expression of the gene encoding the high-K m glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy
Authors
R. Li
B. Thorens
M. R. Loeken
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0579-7

Other articles of this Issue 3/2007

Diabetologia 3/2007 Go to the issue

Article

Single nucleotide polymorphisms in the neuropeptide Y2 receptor (NPY2R) gene and association with severe obesity in French white subjects

Short Communication

The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations

Short Communication

PPARGC1A coding variation may initiate impaired NEFA clearance during glucose challenge

Article

Studies of the associations between functional β2-adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects

Article

Regulation of pancreatic endocrine cell differentiation by sulphated proteoglycans

Short Communication

Post-translational protein modifications in type 1 diabetes: a role for the repair enzyme protein-l-isoaspartate (d-aspartate) O-methyltransferase?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits